Biogen, Inc. (BIIB)
Biogen Market Cap: 24.18B for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 931.32B |
| AbbVie, Inc. | 377.67B |
| Stoke Therapeutics, Inc. | 1.607B |
| Alnylam Pharmaceuticals, Inc. | 46.67B |
| Insmed, Inc. | 34.92B |
Market Cap Related Metrics
| PE Ratio | 15.03 |
| PS Ratio | 2.494 |
| Price to Book Value | 1.328 |
| Price to Free Cash Flow | 10.68 |
| Price | 164.82 |
| Earnings Yield | 6.65% |
| Operating PE Ratio | 9.908 |
| Normalized PE Ratio | 13.33 |